The hazard ratio of AD for patients receiving angiotensin-converting enzyme inhibitors (0.98, 0.83–1.14) and for those receiving direct renin inhibitors (0.94, 0.64–1.40) was not significantly different as compared to those receiving angiotensin-receptor blockers. The gene discussed is ACE; the disease is Alzheimer disease.